Journal: International Journal of Molecular Sciences
Article Title: Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3
doi: 10.3390/ijms26146877
Figure Lengend Snippet: Influence of FAKi on the replication and cytotoxicity of PD-H. ( A ) Viral growth curves. MIA Paca-2 and Capan-1 cells were infected with 3 and 0.1 MOI of PD-H for 1 h and thereafter incubated with medium containing the FAKi VS-4718, VS-6062, CEP-37440, or Defactinib at indicated concentrations, or DMSO, or cell culture medium alone for 24 h. Virus titers were determined by plaque assay on HeLa cells. Shown are mean values ± SD from 3 independent experiments. Statistical significance compared to PD-H + DMSO, * p < 0.05, ** p < 0.01, and *** p < 0.001; n.s., not significant. ( B ) Cell viability of the PD-H/FAKi approach described under ( A ). Cell viability was determined by XTT assay 24 h post-treatment. Data were set relative to DMSO-treated cells. Statistical significance compared to non-treated cells, * p < 0.05 and *** p < 0.001; n.s., not significant.
Article Snippet: The Inhibitors of the FAK VS-4718 (PND-1186), Ifebemtinib (BI-853520), VS-6062 (PF-00562271), GSK2256098, CEP-37440, and Defactinib (VS-6063) were purchased as 100% DMSO dissolved solution (10 mM) from MedChemExpress (Sollentuna, Sweden) and stored as aliquots at −80 °C up to use.
Techniques: Infection, Incubation, Cell Culture, Virus, Plaque Assay, XTT Assay